NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioMedPartners

BioMedPartners

Baselbiomedvc.com

Overview

BioMedPartners is a Swiss venture capital firm specializing in early- to mid-stage life science and healthcare investments across Europe.

Year Founded

2002

Portfolio Companies

19

Investments

BioMedPartners investments
CompanyDateStageLead
iDEL TherapeuticsMar 2026SeedLead
iDEL TherapeuticsMar 2026SeedLead
T-CURX GmbHDec 2025Series ALead
AzafarosMay 2025Series BCo-investor
ImmunOs TherapeuticsSep 2024Series C-
View all investments

Key People

Markus Hosang

General Partner

Thomas Möller

Managing General Partner

Stefan Fäs

CFO & Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBasel
Year Founded2002

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.